Seattle's Omeros Fires Back But Still Won't Answer Basic Questions About Key Drug Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017SEATTLE Omeros Corporation… Source: BioSpace You Might Also Like Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges September 6, 2017 3 Resume Tweaks to Help Scientists Get a Job in the Private Sector February 22, 2018 GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz February 4, 2018
